Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#21 / 200 Total
LPSN - Liveperson Inc - Stock Price Chart
CompanyLiveperson Inc
IndustrySoftware - Application
Market Cap102.67MEPS (ttm)-1.28
P/E-EPS this Y-102.92%
Forward P/E-EPS next Y-2100.00%
PEG-EPS past 5Y-24.76%
P/S0.26EPS next 5Y25.00%
P/B2.21EPS Q/Q12.26%
Dividend-Sales Q/Q-22.05%
Insider Own20.22%Inst Own69.75%
Insider Trans12.41%Inst Trans-1.37%
Short Float7.76%EarningsFeb 28/a
Analyst Recom3.00Target Price2.00
Avg Volume1.77M52W Range2.30 - 12.03
Feb-29-24Downgrade ROTH MKM Buy → Neutral $6 → $2
VHAI - Vocodia Holdings Corp. - Stock Price Chart
CompanyVocodia Holdings Corp.
IndustrySoftware - Infrastructure
Market Cap5.84MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S7.21EPS next 5Y-
Dividend-Sales Q/Q-92.40%
Insider Own47.62%Inst Own-
Insider Trans0.00%Inst Trans-
Short Float-Earnings-
Analyst Recom-Target Price-
Avg Volume3.16M52W Range1.13 - 5.88
VIEW - View Inc. - Stock Price Chart
CompanyView Inc.
IndustryBuilding Products & Equipment
Market Cap6.63MEPS (ttm)-67.86
P/E-EPS this Y48.13%
Forward P/E-EPS next Y56.91%
PEG-EPS past 5Y-
P/S0.05EPS next 5Y-
P/B-EPS Q/Q-13786.02%
Dividend-Sales Q/Q60.85%
Insider Own32.84%Inst Own31.80%
Insider Trans-25.42%Inst Trans-46.32%
Short Float2.39%EarningsNov 14/a
Analyst Recom3.00Target Price180.00
Avg Volume1.96M52W Range0.62 - 44.05
CSTL - Castle Biosciences Inc - Stock Price Chart
CompanyCastle Biosciences Inc
IndustryDiagnostics & Research
Market Cap485.99MEPS (ttm)-2.15
P/E-EPS this Y-6.28%
Forward P/E-EPS next Y15.55%
PEG-EPS past 5Y-28.57%
P/S2.21EPS next 5Y-
P/B1.27EPS Q/Q87.78%
Dividend-Sales Q/Q72.47%
Insider Own7.07%Inst Own85.22%
Insider Trans-12.37%Inst Trans-2.07%
Short Float5.01%EarningsFeb 28/a
Analyst Recom1.11Target Price31.67
Avg Volume245.90K52W Range9.26 - 26.70
RVSN - Rail Vision Ltd - Stock Price Chart
CompanyRail Vision Ltd
Market Cap8.58MEPS (ttm)-4.86
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-63.85%
P/S61.29EPS next 5Y-
P/B1.36EPS Q/Q33.28%
Dividend-Sales Q/Q-29.70%
Insider Own45.24%Inst Own1.57%
Insider Trans0.00%Inst Trans-
Short Float14.20%EarningsNov 24/b
Analyst Recom1.00Target Price56.00
Avg Volume5.48M52W Range1.01 - 23.37
VANI - Vivani Medical Inc - Stock Price Chart
CompanyVivani Medical Inc
Market Cap215.35MEPS (ttm)-0.53
P/E-EPS this Y-44.44%
Forward P/E-EPS next Y-15.38%
PEG-EPS past 5Y50.89%
P/S-EPS next 5Y-
P/B8.22EPS Q/Q-460.54%
Dividend-Sales Q/Q-
Insider Own49.10%Inst Own6.78%
Insider Trans3.10%Inst Trans477.46%
Short Float0.71%EarningsNov 14/b
Analyst Recom1.00Target Price4.00
Avg Volume2.88M52W Range0.75 - 7.80
ACHL - Achilles Therapeutics Plc ADR - Stock Price Chart
CompanyAchilles Therapeutics Plc ADR
CountryUnited Kingdom
Market Cap53.83MEPS (ttm)-1.90
P/E-EPS this Y47.25%
Forward P/E-EPS next Y83.33%
PEG-EPS past 5Y-
P/S-EPS next 5Y5.20%
P/B0.35EPS Q/Q-31.60%
Dividend-Sales Q/Q-
Insider Own4.35%Inst Own45.70%
Insider Trans0.00%Inst Trans0.49%
Short Float0.09%EarningsNov 13/a
Analyst Recom2.50Target Price4.25
Avg Volume722.70K52W Range0.74 - 1.58
OCEA - Ocean Biomedical Inc. - Stock Price Chart
CompanyOcean Biomedical Inc.
Market Cap59.96MEPS (ttm)-3.25
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-3415.71%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own13.75%
Insider Trans0.00%Inst Trans8.10%
Short Float10.62%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume3.86M52W Range0.52 - 12.08
Feb-29-24 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting (GlobeNewswire) +14.29%
Dec-05-23 09:45AM EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody (Benzinga)
08:15AM Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody (GlobeNewswire)
Nov-29-23 05:41PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) -8.95%
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
Nov-01-23 07:00AM Presenting on the Emerging Growth Conference 64 Day 2 on November 2 Register Now (GlobeNewswire)
Oct-31-23 07:00AM Presenting on the Emerging Growth Conference 64 Day 1 on November 1 Register Now (GlobeNewswire)
Oct-26-23 06:30AM EXCLUSIVE: Ocean Biomedical's JV Partner Virion Therapeutics Dosed First Patients In Novel Immunotherapy Study For Chronic Hepatitis B (Benzinga)
05:30AM Virion Therapeutics and Joint Venture Partner, Ocean Biomedical (NASDAQ: OCEA), Announce First Patients Dosed with Novel Immunotherapy Evaluating a Functional Cure for Chronic Hepatitis B Virus Infection (PR Newswire)
05:30AM Ocean Biomedical (NASDAQ: OCEA) Announces First Patients Dosed by Joint Venture Partner Virion Therapeutics in Phase 1b Study of Novel Immunotherapy for Chronic Hepatitis B Virus Infection (GlobeNewswire)
INSG - Inseego Corp - Stock Price Chart
CompanyInseego Corp
IndustryCommunication Equipment
Market Cap36.12MEPS (ttm)-4.26
P/E-EPS this Y55.98%
Forward P/E-EPS next Y35.31%
PEG-EPS past 5Y-28.82%
P/S0.18EPS next 5Y20.00%
P/B-EPS Q/Q9.75%
Dividend-Sales Q/Q-19.20%
Insider Own20.22%Inst Own36.39%
Insider Trans0.00%Inst Trans-36.87%
Short Float7.88%EarningsFeb 21/a
Analyst Recom3.00Target Price4.00
Avg Volume98.06K52W Range1.62 - 12.30
CC - Chemours Company - Stock Price Chart
TickerCC [NYSE]
CompanyChemours Company
IndustrySpecialty Chemicals
Market Cap2.92BEPS (ttm)-2.08
P/E-EPS this Y-36.01%
Forward P/E5.45EPS next Y21.07%
PEG-EPS past 5Y-1.34%
P/S0.49EPS next 5Y7.40%
P/B3.87EPS Q/Q-91.24%
Dividend5.06%Sales Q/Q-16.32%
Insider Own1.17%Inst Own76.73%
Insider Trans0.00%Inst Trans0.20%
Short Float3.16%EarningsFeb 28/a
Analyst Recom2.82Target Price30.78
Avg Volume1.63M52W Range22.88 - 39.05
Feb-29-24Downgrade BMO Capital Markets Outperform → Underperform $45 → $19